Skeletal muscle: An endocrine organ

Clinical Cases in Mineral and Bone Metabolism

Volumn 10, Issue 1, 2013, Pages 11-14

  Pratesi, Alessandra ^a   Tarantini, Francesca ^a   Di Bari, Mauro ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Aging; Myokine; Sarcopenia; Skeletal muscle

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; THYROID HORMONE;

ACUTE CORONARY SYNDROME; AGING; ATHEROSCLEROSIS; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; DEMENTIA; DEPRESSION; DETERIORATION; DIABETES MELLITUS; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; IMMOBILIZATION; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; MAJOR DEPRESSION; MUSCLE MASS; MUSCLE STRENGTH; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; REVIEW; SARCOPENIA; SEDENTARY LIFESTYLE; SKELETAL MUSCLE;

EID: 84878337332     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: 10.11138/ccmbm/2013.10.1.011     Document Type: Review

References (49)

1. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147: 755-763.
2. Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci 1995;50: 5-8.
3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39: 412-23.
4. Solomon AM, Bouloux PMG. Modifying muscle mass - the endocrine perspective. J Endocrinol 2006;191: 349-360.
5. Sakuma K, Yamaguchi A. Sarcopenia and age-related endocrine function. Int J Endocrinol 2012;2012:127362.
6. Pedersen BK. Muscle and their myokines. J Exp Biol 2011;214: 337-346.
7. Pedersen BK. The diseasome of physical inactivity- and role of myokines in muscle - fat cross talk. J Physiol 2009;587: 5559-5568.
8. Brandt C, Pedersen BK. The Role of Exercise-Induced Myokines in Muscle Homeostasis and the Defense against Chronic Diseases. J Biomed Biotechnol 2010; 2010:520258.
9. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol 2005;78: 819-835.
10. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005;98: 1154-62.
11. Pedersen BK, Steensberg A, Fischer C, et al. Searching for the exercise factor: is IL-6 a candidate? J Muscle res Cell Motil 2003;24: 113-9.
12. Steensberg A, van Hall G, Osada T, et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 2000;529: 237-242.
13. Pedersen BK, Febbraio MA. Muscle as endocrine organ: focus on musclederived interleukin-6. Physiol Rev 2008;88: 1379-1406.
14. Keller C, Steensberg A, Pilegaard H, et al. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 2001;15: 2748-2750.
15. Hiscock N, Chan MH, Bisucci T, et al. Skeletal myocytes are a source a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 2004;18: 992-4.
16. Malm C, Nyberg P, Engstrom M, et al. Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol 2000;529: 243-262.
17. Penkowa M, Keller C, Keller P, et al. Immunohistochemical detection of interleukin-& in human skeletal muscle fibers following exercise. FASEB J 2003;17: 2166-2168.
18. Febbraio MA, Pedersen BK. Muscle-derived inteleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002;11: 1335-1347.
19. Kanemaki T, Kitade H, Kaibori M, et al. Interleukin 1 beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 1998;27: 1296-1303.
20. Carey AL, Stenberg GR, Macaulay SL, et al. IL-6 increases insulin stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMPK. Diabetes 2006;55: 2688-2697.
21. DiCosmo BF, Picarella D, Flavell RA. Local production of human IL6 promotes insulitis but retards the onset of-insulin-dependent diabetes mellitus in non-obese diabetic mice. Int Immunol 1994;6: 1829-1837.
22. Wallenius W, Wallenius K, Ahren B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat med 2002;8: 75-79.
23. Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;75: 40-47.
24. Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, cortisol in humans. Am J Physiol Endocrinol Metab 2003;285: 433-437.
25. Nielsen AR, Pedersen BK. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab 2007;32: 833-9.
26. Nielsen AR, Hojman P, Erikstrup C, et al. Association between interleukin- 15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab 2008;11: 4486-93.
27. Matthews VB, Aström MB, Chan MH, et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 2009;52: 1409-18.
28. Laske C, Stransky E, Leyhe T, et al. Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 2006;113: 1217-24.
29. Conner JM, Lauterborn JC, Yan Q, et al. Distribution of Brain-Derived Neurotrophic Factor (BDNF) Protein and mRNA in the Normal Adult Rat CNS: Evidence for Anterograde Axonal Transport. J Neurosci 1997;17: 2295-2313.
30. Karege F, Perret G, Bondolfi G, et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002;109: 143-148.
31. Manni L, Nikolova V, Vyagova D, Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol 2005;102: 169-171.
32. Krabbe KS, Nielsen AR, Krogh-Madsen R, et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007;50: 431-8.
33. Whitmer RA, Gustafson DR, Barrett-Connor E, et al. Central obesity and increased risk of dementia more than three decades later. Neurology 2008;71: 1057-64.
34. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86: 836-42.
35. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007;86: 823-35.
36. Nieman DC, Henson DA, Smith LL, et al. Cytokine changes after marathon race. J Appl Physiol 2001;91: 109-114.
37. Akerstrom TC, Steensberg A, Keller P, et al. Exercise induces interleukin- 8 expression in human skeletal muscle. J Physiol 2005;563: 507-516.
38. Austin L, Bower J, Kurek J, Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. Journal of the neurological sciences 1992;11: 185-191.
39. Hunt L, Tudor E, White J. Leukaemia inhibitory facto-dependent increase in myoblast cell number is associated with phosphotidylinositol 3-kinasemediated inhibition of apoptosis and not mitosis. Experimental Cell Research 2010;316: 1002-1009.
40. Ostan R, Bucci L, Capri M, et al. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 2008;15: 224-40.
41. Candor G, Caruso C, Colonna-Romano G. Inflammation, genetic background and longevity. Biogerontology 2010;11: 565-573.
42. Franceschi C, Bonafè M. Centenarians as a model for healthy aging. Biochem Soc Trans 2003;31: 457-61.
43. Handschin C, Spiegelman BM. The role of exercise and PGC1alfa in inflammation and chronic disease. Nature 2008;454: 463-469.
44. Visser M, Pahor M, Taaffe DR, et al. Relationship of IL6 and TNF-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC study. J Geront A Bio Sci Med Sci 2002; 57: 326-332.
45. Shaap L, Pluijm S, Deeg D, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J med 2006;119:526.e9-526.e17.
46. Fried LP, Tangen CM, Waltson J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Bio Sci Med Sci 2001;56: 146-156.
47. Wong CH, Weiss D, Sourial N, et al. Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in montreal: a cross-sectional study. Aging Clin Exp Res 2010;22: 54-62.
48. Baggio G, Donazzan S, Monti D, et al. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J 1998;12: 433-437.
49. Nocon M, Hiemann T, Muller-Riemenschneider F, et al. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiov Prev R 2008;15: 239-246.